SciELO - Scientific Electronic Library Online

 
vol.32 issue2Risk factors for psychomotor development among infants born under optimal biological conditionsComparison of methods to test an "in vitro" test of cytotoxicity of biocompatible hospital materials author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista de Saúde Pública

Print version ISSN 0034-8910

Abstract

PINTO, Anna L. R.; RAYMOND, Kimiyo M.; BRUCK, Isac  and  ANTONIUK, Sérgio A. Neonatal screening for biotinidase deficiency. Rev. Saúde Pública [online]. 1998, vol.32, n.2, pp. 148-152. ISSN 0034-8910.  http://dx.doi.org/10.1590/S0034-89101998000200007.

INTRODUCTION: Biotinidase deficiency is an inheritable disorder of biotin metabolism. This disorder fulfills major criteria for consideration for newborn screening: the affected children do not show clinical signs in the newborn period; the disease is highly disabling; treatment is effective in preventing neurological sequelae if undertaken promptly. MATERIAL AND METHODS: Screening of 125,000 infants born in Paraná State was carried out to establish the prevalence of biotinidase deficiency. A simple colorimetric procedure was used to detect two infants with biotinidase deficiency (1:62,500), one of them with profound deficiency (1:125,000) and the other with partial deficiency (1:125,000) of the enzyme. RESULTS: There were no known false-negative test results and 0.12% were false-positive, defined by further blood samples which were negative upon repeated testing. Sensitivity was 100% and specificity was 99.88%. Repeat blood samples could not be obtained in 63 (30%) suspected cases. CONCLUSIONS: Newborn screening for biotinidase is useful in identifying affected children, is inexpensive and allows early intervention, which may prevent irreversible neurological damage.

Keywords : Biotina; Prevalence.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese